Mraovitch S. , Sercombe R.Neurophysiological Basis of Cerebral Blood Flow Control- An Introduction. London: John Libbey, 1996:1-408.
3.
Faraci FM, Heistad DDRegulation of large cerebral arteries and cerebral microvascular pressure . Circ Res1990;66:8-17.
4.
Welch KMA, Caplan LR, Reis DJ, Siesjö, Weir B (eds) Primer on Cerebrovascular Diseases . New York: Academic Press , 1997:1-823.
5.
Mayhan WG, Faraci FM, Baumbach GL, Heistad DDEffects of aging on responses of cerebral arterioles. Am J Physiol1990; 258:H1138-H1143.
6.
Lartaud I., Makki T., Bray-des-Boscs L. et al. Effect of chronic Ang 1-converting enzyme inhibition on aging processes. IV. Cerebral blood flow regulation. Am J Physiol1994;267:R687-R694.
7.
Squire IBActions of angiotensin II on CBF autoregulation in health and disease . J Hypertens1994;12:1203-8.
8.
Edvinsson L, MacKenzie E T, McCulloch J. (eds) Cerebral Blood Flow and Metab. New York: Raven Press, 1993:1-683.
9.
Reis DJ, Iadecola C.Intrinsic central neural regulation of CBF and metabolism in relation to volume transmission. In: Fuxe K, and Agnati LF (eds) Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission. New York: Raven Press, 1991;523-38.
10.
Page IHHypertension Mechanisms. New York: Grune & Startton, 1987:1-1002.
11.
Saavedra JMBrain and pituitary angiotensin. Endocr Rev1992;13:329-80.
12.
Saavedra JMEmerging features of brain Angiotensin receptors. Reg Peptides1999; 85:31-45.
13.
Timmermans Pbmwm, InagamiT., Saavedra JM,Ardaillou R., Rosenfeld CR, Mendelsohn FAO.Angiotensin receptor subtypes and their pharmacology. In: Cuello AC, Collier B (eds) Pharmacological Sciences: Perspectives for Research and Therapy in the Late 1990's. Basel, Switzerland: Birkhguser Verlag, 1995:37-58.
14.
Inagami T., Guo D-F., Kitami Y.Molecular biology of angiotensin II receptors: An overview. J Hypertens1994;12 (Suppl. 10):S83-S94.
15.
Mendelsohn FAO , Quirion R., Saavedra JM, Aguilera G., Catt KJAutoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci USA1984;81:1575-9.
16.
Tsutsumi K., Saavedra JMCharacterization and development of angiotensin-II receptor subtypes (AT1 and AT2) in rat brain. Am J Physiol1991 ;261:R209-R216.
17.
Tsutsumi K. , Saavedra JMIncreased dithiothreitol-insensitive, type 2 angiotensin II receptors in selected brain areas of young rat. Cell Mol Neurobiol1991;11:295-9.
18.
Tsutsumi K. , Saavedra JMQuantitative autoradiography reveals different Angiotensin II receptor subtypes in selected rat brain nuclei. J Neurochem1991;56:348-51.
19.
Tsutsumi K. , Saavedra JMDifferential development of angiotensin II receptor subtypes in the rat brain. Endocrinol1991;128:630-2.
20.
Shigematsu K., Saavedra JM, Plunkett LM, Kurihara M., Correa FMA.Angiotensin II binding sites in the anteroventralthird ventricle (AV3V) area and related structures of the rat brain. Neurosci Lett1986;67:37-41.
21.
Tsutsumi K. , Saavedra JMCharacterization of AT2 angiotensin II receptors in rat anterior cerebral arteries. Am J Physiol1991;261:H667-H670.
22.
Nishimura Y. , Ito T., Saavedra JMAngiotensin II AT1 blockade normalises cerebrovascular autoregulation and reduces cerebral ischemia in spontaneously hypertensive rats. Stroke2000 ; 31:2478-86.
23.
Brecher P., Tercyak A., Chobanian AVProperties of angiotensin-converting enzyme in intact cerebral micro vessels . Hypertension1981;3:198-204.
24.
Perich R., Jackson B., Paxton D., Johnston C.Characterization of angiotensin converting enzyme in isolated cerebral microvessels from spontaneously hypertensive and normotensive rats. J Hypertens1992;10:149-53.
25.
Speth RC, Harik SIAngiotensin II receptor binding sites in brain microvessels. Proc Natl Acad Sci USA1985; 82:6340-3.
26.
Saavedra JM , Nishimura Y.Angiotensin and cerebral blood flow. Cell Molec Neurobiol1999;19:553-73.
27.
Näveri L., Strömberg C., Saavedra JMAngiotensin II AT1, receptor mediated contraction of the perfused rat cerebral artery. NeuroReport1994;5:2278-80.
28.
Barry DI, Jarden JO, Paulson OB, Graham DI, Strandgaard S.Cerebrovascular aspects of converting-enzyme inhibition. 1: Effects of intravenous captopril in spontaneously hypertensive and normotensive rats . J Hypertens1984;2:589-97.
29.
Postiglione A.,Bobkiewicz T.,Vinholdt-Pedersen E., Lassen N., Paulson OB, Barry DICerebrovascular effects of angiotensin converting enzyme inhibition involve large artery dilatation in rats. Stroke1991;22:1363-8.
30.
Paulson OB, Waldemar G.Role of the local renin-angiotensin system in the autoregulation of the cerebral circulation. Blood Vessels1991 ;28:231-5.
31.
Bray L., Lartaud I., Muller F.,Atkinson J., Capdeville C.Effects of the angiotensin I converting enzyme inhibitor perindopril on cerebral blood flow in awake hypertensive rats. Am J Hypertens1991;4:246S-252S.
32.
Torup M., Waldemar G., Paulson OBCeranapril and cerebral blood flow autoregulation. J Hypertens1993;1:399-405.
33.
Frei A., Muller-Brand J.Cerebral blood flow and antihypertensive treatment with enalapril . J Hypertens1986;4:365-7.
34.
Waldemar G. , Ibsen H., Strandgaard S., Andersen AR, Reasmissen S., Paulson OBThe effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension . Am J Hypertens1990;13:464-70.
35.
Toyoda K., Fujii K., lbayashi S. et al. Attenuation and recovery of brain stem autoregulation in spontaneously hypertensive rats. J Cereb Blood Flow Metab1998;18:305-10.
36.
Hajdu MA, Heistad DD, Ghoncim S., Baumbach GFEffects of antihypertensive treatment on composition of cerebral arterioles . Hypertension1991;18 (Suppl. 11):1115-21.
37.
Fujii K., Weno BL, Baumbach GL, Heistad DDEffects of antihypertensive treatment on focal cerebral infarction . Hypertension1992;19:713-6.
38.
Sadoshima S. , Nagao T., lbayashi S., Fujishima M.Inhibition of angiotensin-converting enzyme modulates the autoregulation of regional cerebral blood flow in hypertensive rats. Hypertension1994;23:781-5.
39.
Werner C., Hoffman WE, Kochs E., Rabito SF, Miletich DJCaptopril improves neurologic outcome from incomplete cerebral isclemia in rats. Stroke1991;22:910-14.
40.
Veniant M., Clozel JP, Kuhn P., Clozel M.Protective effect of cilazapril on the cerebral circulation. J Cardiovasc Pharmacol1992;19 (Suppl. 6):S94-S99.
41.
Moreau P.,Takase H., Kung CF, van Rooijen MM, SchaffnerT,Luscher TFStructure and function of the rat basilar artery during chronic nitric oxide synthase inhibition . Stroke1995;26:1922-8.
42.
Nag S., Kilty DWCerebrovascular changes in chronic hypertension. Protective effects of enalapril in rats. Stroke1997;28:1028-34.
43.
Naritomi H. , Shimizu T., Watanabe Y., Murata S., Sawada T.Effects of the Angiotensin converting enzyme inhibitor alacepril on cerebral blood flow in hypertensive stroke patients: A pilot study. Curr Ther Res1994;55:1446-54.
44.
Dyker AG, Grosset DG, Lees K.Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke1997;28:580-3.
45.
Näveri L., Strömberg C., Saavedra JMAngiotensin II AT2 receptor stimulation extends the upper limit of cerebral blood flow autoregulation: Agonist effects of CGP 42112 and PD 123319 . JCereb Blood Flow Metab1994;14:38-44.
46.
Strömberg C. , Näveri L., Saavedra JMAngiotensin AT2 receptors regulate CBF in rats. Neuroreport1992;3:703-4.
47.
Inada Y., Wada T., Ojima M. et al. Protective effects of Candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke prone spontaneously hypertensive rats. Clin Expr Hypertens1997 ;19:1079-99.
48.
Fornes P., Richer C., Vacher E., Bruneval P., Giudicelli JFLosartan's protective effects in stroke-prone spontaneously hypertensive rats persist durably after treatment withdrawal. J Cardiovasc Pharm1993;22:305-13.
49.
Wada T., Kanagawa R., Ishimura Y., Inada Y., Nishikawa K.Role of angiotensin II in cerebrovascular and renal damage in deoxyorticosterone acetate-salt hypertensive rats. J Hypertens1995;13:113-22.
50.
Gutkind JS, Kurihara M., Saavedra JMIncreased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol1988;255:H646-H650.
51.
Vraamak T., Waldemar G., Strandgaard S., Paulson S.Angiotensin II receptor antagonist CV-11974 and cerebral blood flow autoregulation . J Hypertens1995;13:755-61.
52.
Nishimura Y. , Xu T., Jöhren O., Häuser W., Saavedra JMThe angiotensin AT1, receptor antagonist CV-11974 regulates CBF and brain angiotensin AT1, receptor expression. Basic Res Cardiol1998 ; 93: (Suppl 2):63-8.
53.
Nazarali AJ , Gutkind JS, Saavedra JMCalibration of [125I]-polymer standards with [125I]-brain paste standards for use in quantitative receptor autoradiography . J Neurosci Meth1989;30:247-53.
54.
Dirnagl U., Kaplan B., Jacewicz M., Pulsinelli W.Continuous measurement of cerebral cortical blood flow by laser-Doppler flowmetry in a rat stroke model. J Cereb Blood Flow Metab1989; 9:589-96.
55.
Zea Longa E. , Weinstein PR, Carlson S., Cummins R.Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke1989;20:84-91.
56.
Bederson JB , Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HMEvaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke1986;17:1304-8.
Nishimura Y. , Ito T., Hoe K-L., Saavedra JMChronic peripheral administration of the angiotensin II AT1 receptor antagonist Candesartan blocks brain AT1-receptors. Brain Res2000; 871:29-38.
59.
Liu Y., Mituska S., Hashizuma K., Hosaka T., Nukui H.The sequential change of local CBF and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effects of MK-801 on local cerebral glucose metabolism. Acta Neurochir (Wien)1997;139:770-79.
60.
Werner C., Hoffman WE, Kochs E., Rabito SF, Miletich DJCaptopril improves neurologic outcome from incomplete cerebral ischemia in rats. Stroke1991;22:910-14.
61.
Dai W-J. , Funk A., Herdegen T., Unger T., Culman J.Blockade of central angiotensin AT1 receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats. Stroke1999; 30:2391-9.
62.
Nobile-Orazio E., Sterzi R.Cerebral ischemia after nifedipine treatment . Br Med J (Clin Res Ed)1981 ;283:948.
63.
Blezer ELA , Klaas N., Bar D. et al. Enalapril prevents imminent and reduces manifest cerebral edema in stroke-prone hypertensive rats. Stroke1998;29:1671-8.
64.
Griendling KK , Ushio-Fukai M.NADH/NADPH oxidase and vascular function. Trends Cardiovasc Med1997;7:301-7.
65.
Pueyo ME,Arnal J.-F, Rami J., Michel J.-B. Angiotensin stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol1998;274:C214-C220.
66.
Wei EP, Ellison MD, Kontos HA, Povlishock JTO2 radicals in arachidonate-induced increased blood brain barrier permeability to proteins. Am J Physiol1986 ;251:H693-H699.
67.
Lees KR, Dyker AGBP control after acute stroke. J Hypertens Suppl1996;14:S35-S38.
68.
Paxinos G., Watson Ch. The rat brain in stereotaxic coordinates. NewYork :Academic Press, 1986:1-118.
